Malecki M - Search Results

1

Recombinant adeno-associated viruses (rAAV2) facilitate the intraperitoneal gene delivery to cancer cells.

Malecki M, Proczka R, Chorostowska-Wynimko J, Swoboda P, Delbani A, Pachecka J. Malecki M, et al. Oncol Lett. 2010 Jan;1(1):177-180. doi: 10.3892/ol_00000032. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966278 Free PMC article.

2

In vivo study of angiogenic plasmid preparations--the bicistronic plasmid as a new type of drug for vascular diseases.

Małecki M, Swoboda P, Jastrzebski Z, Janik P. Małecki M, et al. Acta Pol Pharm. 2004 Jul-Aug;61(4):289-95. Acta Pol Pharm. 2004. PMID: 15575596 Free article.

3

Angiogenic and antiangiogenic gene therapy.

Malecki M, Kolsut P, Proczka R. Malecki M, et al. Gene Ther. 2005 Oct;12 Suppl 1:S159-69. doi: 10.1038/sj.gt.3302621. Gene Ther. 2005. PMID: 16231050 Review.

4

Effect of transfection with a gene coding for the fibronectin FNIII/10 fragment upon contact inhibition of C3H10T1/2 fibroblasts.

Miłoszewska J, Szaniawska B, Trembacz H, Gos M, Przybyszewska M, Swoboda P, Małecki M, Janik P. Miłoszewska J, et al. Among authors: malecki m. Cell Prolif. 2006 Jun;39(3):195-203. doi: 10.1111/j.1365-2184.2006.00382.x. Cell Prolif. 2006. PMID: 16671997 Free PMC article.

5

Vascular-endothelial growth factor (VEGF) in patients with peripheral ischemia.

Proczka RM, Małecki M, Chorostowska-Wynimko J, Polański JA. Proczka RM, et al. Among authors: malecki m. J Physiol Pharmacol. 2006 Sep;57 Suppl 4:305-11. J Physiol Pharmacol. 2006. PMID: 17072059

6

Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.

Małecki M, Swoboda P, Pachecka J. Małecki M, et al. Acta Pol Pharm. 2009 Jan-Feb;66(1):93-9. Acta Pol Pharm. 2009. PMID: 19226976 Free article.

7

Soluble TNF-α receptor I encoded on plasmid vector and its application in experimental gene therapy of radiation-induced lung fibrosis.

Przybyszewska M, Miłoszewska J, Rzońca S, Trembacz H, Pyśniak K, Kotlarz A, Swoboda P, Zalewska M, Małecki M. Przybyszewska M, et al. Among authors: malecki m. Arch Immunol Ther Exp (Warsz). 2011 Aug;59(4):315-26. doi: 10.1007/s00005-011-0133-2. Epub 2011 Jun 3. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21633916 Free article.

8

Study of angiogenic gene ointments designed for skin neovascularization.

Hajdukiewicz K, Stachurska A, Proczka R, Małecki M. Hajdukiewicz K, et al. Among authors: malecki m. Med Wieku Rozwoj. 2013 Jan-Mar;17(1):31-6. Med Wieku Rozwoj. 2013. PMID: 23749693

9

Role of v-Raf and truncated form RAF1 in the induction of vascular endothelial growth factor and vascularization.

Malecki M, Seneta M, Miloszewska J, Trembacz H, Przybyszewska M, Janik P. Malecki M, et al. Oncol Rep. 2004 Jan;11(1):161-5. Oncol Rep. 2004. PMID: 14654920

10

Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.

Malecki M, Trembacz H, Szaniawska B, Przybyszewska M, Janik P. Malecki M, et al. Oncol Rep. 2005 Dec;14(6):1565-9. Oncol Rep. 2005. PMID: 16273257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page